Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) EBT: 2020-2025

Historic EBT for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to -$110.5 million.

  • Agilon Health's EBT rose 554.08% to -$110.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$321.2 million, marking a year-over-year decrease of 327.5%. This contributed to the annual value of -$248.8 million for FY2024, which is 2795.61% down from last year.
  • Per Agilon Health's latest filing, its EBT stood at -$110.5 million for Q3 2025, which was up 554.08% from -$104.3 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's EBT registered a high of $8.2 million during Q1 2023, and its lowest value of -$296.9 million during Q2 2021.
  • For the 5-year period, Agilon Health's EBT averaged around -$59.7 million, with its median value being -$30.2 million (2024).
  • As far as peak fluctuations go, Agilon Health's EBT plummeted by 861679.39% in 2021, and later skyrocketed by 115068.7% in 2023.
  • Over the past 5 years, Agilon Health's EBT (Quarter) stood at -$35.6 million in 2021, then fell by 14.87% to -$40.9 million in 2022, then plummeted by 307.77% to -$166.9 million in 2023, then surged by 37.27% to -$104.7 million in 2024, then dropped by 5.6% to -$110.5 million in 2025.
  • Its last three reported values are -$110.5 million in Q3 2025, -$104.3 million for Q2 2025, and -$1.7 million during Q1 2025.